Key Ingredients
Clinical Studies
We conducted a 60-woman comparative clinical trial (registered on CTRI) comparing the effects of standard care (oral contraceptive pills for hormone management, metformin, steroid therapy etc.) of PCOS with our combination Divantri PCOS
The women who were given the Divantri PCOS Pack showed 83-92% improvement across multiple biomedical markers relative to standard of care, in just 4 months, with no significant adverse effects.
Women in the Divantri PCOS cohort (n=30) saw a significant reduction in the size and number of cysts in their ovaries
We tracked the women for 3 months post-trial and saw no reoccurrence of adverse symptoms.
Women in the Divantri PCOS cohort (n=30) saw a significant reduction in their weight during the trial
We tracked the women for 3 months post-trial and saw no reoccurrence of adverse symptoms.
Women in the Divantri PCOS cohort (n=30) also saw great outcomes for key fertility and hormone markers
For Durva Cohort:
of women returned to baseline levels of key reproductive hormones (specifically FSH and LH)
Women conceived during the trial
decrease in weight loss
reduction in cyst number and size
Our PCOS products have also been used in our clinics on an additional cohort of ~50 women. Our data shows that there was an 86% decrease in weight loss and 74% reduction in cyst number and size.